NA
GH icon

NewEdge Advisors’s Guardant Health GH Stock Holding History

NewEdge Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
2,715
+2,167
+395% +$236K ﹤0.01% 2276
2026
Q1 		$50.6K Buy
548
+156
+40% +$15.7K ﹤0.01% 2936
2025
Q4 		$40K Sell
392
-1,000
-72% -$89.5K ﹤0.01% 3020
2025
Q3 		$87K Sell
1,392
-2
-0.1% -$109 ﹤0.01% 2646
2025
Q2 		$72.5K Sell
1,394
-98
-7% -$4.38K ﹤0.01% 2548
2025
Q1 		$63.6K Sell
1,492
-437
-23% -$18.9K ﹤0.01% 2468
2024
Q4 		$58.9K Buy
1,929
+230
+14% +$6.47K ﹤0.01% 2468
2024
Q3 		$39K Buy
1,699
+1,000
+143% +$28.3K ﹤0.01% 2517
2024
Q2 		$20.2K Sell
699
-369
-35% -$8.59K ﹤0.01% 2622
2024
Q1 		$22K Buy
1,068
+701
+191% +$15K ﹤0.01% 2598
2023
Q4 		$9.93K Buy
367
+192
+110% +$5.04K ﹤0.01% 2846
2023
Q3 		$5.19K Buy
175
+149
+573% +$5.24K ﹤0.01% 2799
2023
Q2 		$930 Sell
26
-569
-96% -$16.3K ﹤0.01% 3253
2023
Q1 		$13.9K Sell
595
-707
-54% -$20.2K ﹤0.01% 2462
2022
Q4 		$19.2K Buy
+1,302
New +$59.6K ﹤0.01% 2136
2021
Q3 		– Sell
-3,406
Closed -$423K – 1169
2021
Q2 		$423K Buy
+3,406
New +$458K 0.01% 791
2021
Q1 		– Sell
-9,529
Closed -$1.23M – 1066
2020
Q4 		$1.23M Buy
+9,529
New +$1.1M 0.04% 369
2020
Q2 		– Sell
-12,756
Closed -$888K – 899
2020
Q1 		$888K Buy
12,756
+76
+0.6% +$5.83K 0.04% 335
2019
Q4 		$990K Buy
+12,680
New +$914K 0.04% 358

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

NewEdge Advisors's GH Position: Q2 2026 in Review

NewEdge Advisors increased its Guardant Health (GH) stake by 395% in Q2 2026, buying an estimated $236K and bringing the position to 2,715 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

NewEdge Advisors first reported a position in GH in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.23M in Q4 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • NewEdge Advisors held 2,715 shares of Guardant Health worth $407K as of Q2 2026.
  • NewEdge Advisors bought 2,167 Guardant Health shares in Q2 2026, an estimated $236K.
  • Guardant Health made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2276 holding.
  • NewEdge Advisors first reported a position in Guardant Health in Q4 2019 and has held it in 19 quarters since.
  • NewEdge Advisors's Guardant Health position peaked at $1.23M in Q4 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.